154 related articles for article (PubMed ID: 31515570)
1. Prognosticators of Long-Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features.
Kuan TC; Chang SC; Lin JK; Lin TC; Yang SH; Jiang JK; Chen WS; Wang HS; Lan YT; Lin CC; Lin HH; Huang SC
World J Surg; 2019 Dec; 43(12):3207-3215. PubMed ID: 31515570
[TBL] [Abstract][Full Text] [Related]
2. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
[TBL] [Abstract][Full Text] [Related]
3. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
[TBL] [Abstract][Full Text] [Related]
4. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
[TBL] [Abstract][Full Text] [Related]
5. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
[TBL] [Abstract][Full Text] [Related]
6. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
[TBL] [Abstract][Full Text] [Related]
7. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
[TBL] [Abstract][Full Text] [Related]
9. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.
Wang C; van Rijnsoever M; Grieu F; Bydder S; Elsaleh H; Joseph D; Harvey J; Iacopetta B
Oncology; 2003; 64(3):259-65. PubMed ID: 12697967
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
[TBL] [Abstract][Full Text] [Related]
13. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
Petrelli F; Ghidini M; Cabiddu M; Pezzica E; Corti D; Turati L; Costanzo A; Varricchio A; Ghidini A; Barni S; Tomasello G
Anticancer Res; 2019 Dec; 39(12):6431-6441. PubMed ID: 31810907
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
17. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
[TBL] [Abstract][Full Text] [Related]
18. Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients.
Kuan TC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Liang WY; Chen WS; Lin JK; Jiang JK; Chang SC
PLoS One; 2018; 13(5):e0197681. PubMed ID: 29795620
[TBL] [Abstract][Full Text] [Related]
19. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
20. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
Wang B; Li F; Zhou X; Ma Y; Fu W
World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]